Please Wait

Applying Filters...

Athena Pharmaceutiques Oral Dispersible Tablets

Athena Pharmaceutiques Oral Dispersible Tablets

X

List of Active Pharmaceutical Ingredients (APIs) for which Written Confirmation(s) have been obtained by Curia

Curia

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2023, Corporate Presentation, Antibody Based Drug Discovery 2022, Leveraging Immunological Diversity 2022, Leveraging Monoclonal Antibodies 2022, Accelerated API Manufacturing 2022, mRNA Vaccines Therapeutics 2022, Parenteral Manufacturing Outsourcing 2022, GMP Certificate 2022, Recently Filed DMFs 2022, Curia to Expand U.S. Commercial Manufacturing Capability, Curia Expands R&D Capabilities & Biologics FDF, Acquires LakePharma, Curia Expands Biologic FDF Business, Acquires Integrity Bio, Insourcing and Productivity, Solid State Chemistry And Analytical Services, Fine Chemicals Catalog 2021, Product List 2021

VIDEO(s)

Corporate Video, Interview with Jamie Grabowski 2022, AMRI Becomes Curia, Pipeline to Portfolio, Interview with Brandon Zurawlow Interphex 2017

DIGITAL CONTENT

101 News

101 News

APIs // Active Pharmaceutical Ingredients

180 APIs, 124 USDMF, 44 CEP/COS, 25 JDMF, 2 EU WC, 6 KDMF, 8 NDC API, 119 Listed APIs

DEVELOPMENTS

10 Drug(s) in Development

10 Drug(s) in Development

KEY PRODUCTS

Beclomethasone Dipropionate, Ganaxolone, Tapentadol, Viloxazine Hydrochloride

SERVICES

All Services, Analytical, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

EXCIPIENTS

1 Listed Products, 1 Regulatory Filings, 1 USDMF

EXCIPIENTS BY INGREDIENTS

Tyloxapol

Tyloxapol

EXCIPIENTS BY APPLICATIONS

Solubilizers

Solubilizers

INSPECTIONS & REGISTRATIONS

64 FDA, 39 EDQM, 2 WHO-GMP, 9 GDUFA

Curia
EU WC
Full Screen View